DarioHealth Corp. Contract with Customer, Liability, Increase (Decrease) for Contract Acquired in Business Combination
DarioHealth Corp. (DRIO) reported Contract with Customer, Liability, Increase (Decrease) for Contract Acquired in Business Combination of $742.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-10.
Financial Statements › Notes › Change in Contract with Customer, Asset and Liability
us-gaap:ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination · last filed 2025-03-10
- DarioHealth Corp. contract with customer, liability, increase (decrease) for contract acquired in business combination for the quarter ending 2024-12-31 was $0.00.
- DarioHealth Corp. contract with customer, liability, increase (decrease) for contract acquired in business combination for the quarter ending 2024-09-30 was $0.00.
- DarioHealth Corp. contract with customer, liability, increase (decrease) for contract acquired in business combination for the quarter ending 2024-06-30 was $0.00.
- DarioHealth Corp. contract with customer, liability, increase (decrease) for contract acquired in business combination for the quarter ending 2024-03-31 was $742.00K.
- DarioHealth Corp. contract with customer, liability, increase (decrease) for contract acquired in business combination for fiscal 2024 was $742.00K.
| Period end | Contract with Customer, Liability, Increase (Decrease) for Contract Acquired in Business Combination 3 month | Contract with Customer, Liability, Increase (Decrease) for Contract Acquired in Business Combination 6 month | Contract with Customer, Liability, Increase (Decrease) for Contract Acquired in Business Combination 9 month | Contract with Customer, Liability, Increase (Decrease) for Contract Acquired in Business Combination 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10 | $0.00 derived: sum of 2 quarters · filed 2025-03-10 | $0.00 derived: sum of 3 quarters · filed 2025-03-10 | $742.00K 10-K · filed 2025-03-10 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $0.00 derived: sum of 2 quarters · filed 2024-11-07 | $742.00K 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $742.00K 10-Q · filed 2024-08-08 | ||
| 2024-03-31 | $742.00K 10-Q · filed 2024-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |